Mythrocin Powder for Suspension 125 mg/5 ml
Mythrocin Powder for Suspension 125 mg/5 ml Uses, Dosage, Side Effects, Food Interaction and all others data.
| Trade Name | Mythrocin Powder for Suspension 125 mg/5 ml |
| Generic | Erythromycin (Oral) |
| Weight | 125 mg/5 ml |
| Type | Powder for Suspension |
| Therapeutic Class | Anti-diarrhoeal Antimicrobial drugs, Macrolides |
| Manufacturer | Goodman Pharmaceuticals Ltd. |
| Available Country | Bangladesh |
| Last Updated: | October 19, 2023 at 6:27 am |
Uses
Erythromycin is highly effective in the treatment of a wide variety of clinical infections. Upper respiratory tract infections: Tonsilitis, Peritonsillar abscess, Pharyngitis, laryngitis, Sinusitis. Secondary infections in colds and influenza. Lower respiratory tract infections ... Read moreDosage
Mythrocin Powder for Suspension 125 mg/5 ml dosage
Adult and Children over 8 years: 250-500 mg every six hours for mild to moderate infections. This may be increased upto 4 gm. or more daily in severe cases.Elderly: No special dosage recommendation. Erythromycin may be administered if desired, three times daily or twice daily by giving one-third or half of the total daily requirement 8 hourly or 12 hourly respectively. Children aged 2 to 8 years: 250 mg. every six hours or 30-50 mg/kg body weight per day divided into four equal dosage. Infants and Children upto 2 years: 500 mg. in divided doses or 30-50 mg/kg body weight in divided doses.Side Effects
Allergic reactions are rare and mild although anaphylaxis has occurred. Occasionally there is abdominal discomfort after oral administration, sometimes with nausea and vomiting. This discomfort usually subsides after a few days without it being necessary to reduce the dosage.Precaution
Erythromycin should be given with care in patients with impaired hepatic function, as erythromycin is excreted principally in the bile.Interaction
Recent data from studies of erythromycin reveals that its use in patients who are receiving high dosage of theophylline may be associated with an increase of serum theophylline levels and potential theophylline toxicity. In such cases this dose of theophylline should be reduced.Pregnancy & Breastfeeding use
Clinical and Laboratory studies have been shown no evidence in human of teratogenicity or toxicity. However, caution should be exercised when prescribing this drug to pregnant patients and lactating mothers since erythromycin crosses the placental barrier and is excreted in breast milk.Contraindication
Known hypersensitivity to Erythromycin.Acute Overdose
In case of overdosage, Erythromycin should be discontinued. Overdosage should be handled with the prompt elimination of unabsorbed drug and all other appropriate measures should be instituted. Erythromycin is not removed by peritoneal dialysis or haemodialysis.Storage Condition
Keep below 25°C temperature, away from light & moisture. Keep out of the reach of children.Innovators Monograph
You find simplified version here Mythrocin Powder for Suspension 125 mg/5 ml
